People judge weight loss more harshly when GLP-1 drugs are involved, study finds
Even when medication is paired with diet and exercise, people may still feel their weight loss is less…
GLP-1 drugs cut heart and kidney risks in type 1 diabetes study
A major real-world analysis suggests GLP-1 receptor agonists could offer heart, kidney, and weight benefits in type 1…
Study finds GLP-1 medicines cut fat while preserving muscle function
A new study in mice and humans suggests GLP-1 medicines drive weight loss primarily by reducing fat, while…
Patients who stop GLP-1 drugs often restart or try alternatives
A large real-world study shows that patients who stop popular GLP-1–based weight-loss drugs often return to treatment or…
Could GLP-1 drugs help curb addiction? Large veteran study points to potential benefit
A major study of US veterans suggests that GLP-1 diabetes medications may influence addiction-related outcomes, revealing a surprising…
Engineered lettuce may turn injectable GLP-1 therapies into oral pills
Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists.…
Mapping the year-one weight trajectory after stopping GLP-1s
A year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain, on average, 60%…
Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity
Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial of dapiglutide, researchers…
Unprocessed beef does not worsen metabolic health in prediabetes
A controlled crossover trial finds that short-term consumption of unprocessed beef is on par with poultry for glucose…
Improving survival in people with severe psychiatric disorders
An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap…
How bariatric surgery outperforms GLP-1 in body fat loss
A large real-world study reveals how surgery and GLP-1 therapies reshape fat and lean tissue differently over time,…
Glucose-lowering drugs may reduce risk of developing epilepsy
A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to…